Harbin Pharmaceutical

Harbin Pharmaceutical Group (HPGC) is a leading Chinese pharmaceutical company headquartered in Harbin, specializing in the development, manufacturing, and distribution of a diverse range of healthcare products. The company is one of the largest producers of antibiotics and vitamins in China, with a portfolio that includes over-the-counter (OTC) medicines, traditional Chinese medicines, and animal health products. HPGC operates several large-scale manufacturing facilities and has a significant presence in the domestic market through its extensive sales network. In recent years, the company has expanded internationally, most notably through its strategic investment and acquisition of the China operations of the global health and wellness brand GNC. As a state-controlled enterprise, HPGC plays a critical role in the Chinese healthcare system and continues to focus on modernizing its production capabilities and expanding its product pipeline.